Journal
REPRODUCTIVE TOXICOLOGY
Volume 25, Issue 3, Pages 388-389Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.reprotox.2008.03.001
Keywords
topiramate; pregnancy; spontaneous abortions; congenital anomalies
Categories
Ask authors/readers for more resources
In spite of a substantial increase in the use of topirarnate at child bearing age, very little is known regarding its use in pregnancy. We describe the outcome of 52 pregnancies with 41 liveborn infants from which it seems that topiramate reduces birth weight without decreasing gestational age at delivery, but does not seem to increase the risk for structural defects. There was an increased rate of spontaneous abortions not related to the drug effects. (c) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available